RedHill Biopharma Ltd. (RDHL)
NASDAQ: RDHL
· Real-Time Price · USD
1.90
-0.32 (-14.41%)
At close: Oct 03, 2025, 3:59 PM
RedHill Biopharma Revenue
RedHill Biopharma reported an annual revenue of $8.04M, reflecting a 23.17% growth. For the quarter ending June 30, 2025, RedHill Biopharma generated $2.04M in revenue.
Revenue (ttm)
8.04M
Revenue Growth
23.17%
Price / Sales Ratio
1.9
Revenue / Employee
229.8K
Employees
35
Market Cap
4.36M
Revenue Chart
History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 8.04M | +23.17% |
| Dec 31, 2023 | 6.53M | -89.43% |
| Dec 31, 2022 | 61.8M | -27.94% |
| Dec 31, 2021 | 85.76M | +33.25% |
| Dec 31, 2020 | 64.36M | +923.03% |
| Dec 31, 2019 | 6.29M | -24.75% |
| Dec 31, 2018 | 8.36M | +108.63% |
| Dec 31, 2017 | 4.01M | +3867.33% |
| Dec 31, 2016 | 101K | +3266.67% |
| Dec 31, 2015 | 3K | -99.96% |
| Dec 31, 2014 | 7.01M | +58350.00% |
| Dec 31, 2013 | 12K | -25.00% |
| Dec 31, 2012 | 16K | -30.43% |
| Dec 31, 2011 | 23K | +Infinity% |
| Dec 31, 2010 | 0 | n/a |